Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
684
-
Total 13F shares, excl. options
-
95M
-
Shares change
-
+2.69M
-
Total reported value, excl. options
-
$14.6B
-
Value change
-
+$424M
-
Put/Call ratio
-
0.87
-
Number of buys
-
277
-
Number of sells
-
-299
-
Price
-
$154.14
Significant Holders of Labcorp Hldgs Inc. - COM (LH) as of Q2 2017
761 filings reported holding LH - Labcorp Hldgs Inc. - COM as of Q2 2017.
Labcorp Hldgs Inc. - COM (LH) has 684 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (10.4M shares), BlackRock Inc. (7.73M shares), Boston Partners (4.59M shares), STATE STREET CORP (4.59M shares), NORDEA INVESTMENT MANAGEMENT AB (2.7M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (2.66M shares), FMR LLC (1.78M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (1.6M shares), GOLDMAN SACHS GROUP INC (1.55M shares), and UBS ASSET MANAGEMENT AMERICAS INC (1.54M shares).
This table shows the top 684 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.